Cargando…

Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)

Ovarian cancer is a gynecological neoplasm that can be found in women, which, due to diagnostic difficulties, is often detected at advanced stages when treatment becomes a significant problem. Moreover, in a number of cases there is a cancer recurrence and resistance to standard chemotherapy treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Królewska-Daszczyńska, Patrycja, Wendlocha, Dominika, Smycz-Kubańska, Marta, Stępień, Sebastian, Mielczarek-Palacz, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667454/
https://www.ncbi.nlm.nih.gov/pubmed/36406181
http://dx.doi.org/10.3892/ol.2022.13585
_version_ 1784831728426156032
author Królewska-Daszczyńska, Patrycja
Wendlocha, Dominika
Smycz-Kubańska, Marta
Stępień, Sebastian
Mielczarek-Palacz, Aleksandra
author_facet Królewska-Daszczyńska, Patrycja
Wendlocha, Dominika
Smycz-Kubańska, Marta
Stępień, Sebastian
Mielczarek-Palacz, Aleksandra
author_sort Królewska-Daszczyńska, Patrycja
collection PubMed
description Ovarian cancer is a gynecological neoplasm that can be found in women, which, due to diagnostic difficulties, is often detected at advanced stages when treatment becomes a significant problem. Moreover, in a number of cases there is a cancer recurrence and resistance to standard chemotherapy treatment. It has been suggested that cancer stem cells (CSCs) that were not eradicated during therapy may be responsible for this. For this reason, effective therapeutic methods eliminating CSCs are being studied, such as therapy targeting CSCs markers. In addition, numerous studies have also drawn attention to the usefulness of CSCs markers in predicting disease progression and assessing patient's prognosis as well as their importance in the development of treatment resistance. The present review presented research on selected CSCs markers, which may be of significant prognostic and therapeutic importance in ovarian cancer.
format Online
Article
Text
id pubmed-9667454
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-96674542022-11-17 Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review) Królewska-Daszczyńska, Patrycja Wendlocha, Dominika Smycz-Kubańska, Marta Stępień, Sebastian Mielczarek-Palacz, Aleksandra Oncol Lett Review Ovarian cancer is a gynecological neoplasm that can be found in women, which, due to diagnostic difficulties, is often detected at advanced stages when treatment becomes a significant problem. Moreover, in a number of cases there is a cancer recurrence and resistance to standard chemotherapy treatment. It has been suggested that cancer stem cells (CSCs) that were not eradicated during therapy may be responsible for this. For this reason, effective therapeutic methods eliminating CSCs are being studied, such as therapy targeting CSCs markers. In addition, numerous studies have also drawn attention to the usefulness of CSCs markers in predicting disease progression and assessing patient's prognosis as well as their importance in the development of treatment resistance. The present review presented research on selected CSCs markers, which may be of significant prognostic and therapeutic importance in ovarian cancer. D.A. Spandidos 2022-11-07 /pmc/articles/PMC9667454/ /pubmed/36406181 http://dx.doi.org/10.3892/ol.2022.13585 Text en Copyright: © Królewska-Daszczyńska et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Królewska-Daszczyńska, Patrycja
Wendlocha, Dominika
Smycz-Kubańska, Marta
Stępień, Sebastian
Mielczarek-Palacz, Aleksandra
Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)
title Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)
title_full Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)
title_fullStr Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)
title_full_unstemmed Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)
title_short Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)
title_sort cancer stem cells markers in ovarian cancer: clinical and therapeutic significance (review)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667454/
https://www.ncbi.nlm.nih.gov/pubmed/36406181
http://dx.doi.org/10.3892/ol.2022.13585
work_keys_str_mv AT krolewskadaszczynskapatrycja cancerstemcellsmarkersinovariancancerclinicalandtherapeuticsignificancereview
AT wendlochadominika cancerstemcellsmarkersinovariancancerclinicalandtherapeuticsignificancereview
AT smyczkubanskamarta cancerstemcellsmarkersinovariancancerclinicalandtherapeuticsignificancereview
AT stepiensebastian cancerstemcellsmarkersinovariancancerclinicalandtherapeuticsignificancereview
AT mielczarekpalaczaleksandra cancerstemcellsmarkersinovariancancerclinicalandtherapeuticsignificancereview